Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 -0.00129217516152194 0.00244077530509694
Stock impact report

Anti-Theranos: FDA Approval In Hand, Sight Diagnostics Aims At $2.7 Billion Blood Testing Giant, Sysmex [Forbes]

SYSMEX CORP UNSP/ASDR (SSMXY) 
NASDAQ:AMEX Investor Relations: sysmex.co.jp/en/ir/index.html
Company Research Source: Forbes
Anti-Theranos: FDA Approval In Hand, Sight Diagnostics Aims At $2.7 Billion Blood Testing Giant, Sysmex Sysmex Reuters Sysmex did not respond to repeated requests for comment. Sysmex is growing and profitable — enjoying a 14% net profit margin. Its revenues for the year ending March 2019 were $2.7 billion — up 4.1% from the prior year. Sysmex earned net income of $378 million up 5.3% from the year before, according to its 2019 annual report Sysmex is not alone in this industry. Rivals include bioMerieux, Haemonetics, Bio-Techne, Autobio Diagnostics, Guardant Health, Biocept, Epigenomics, Siemens Healthineers, Becton Dickinson, and Danaher. Here’s how OLO works. It takes two drops of blood, turns it into a high resolution image, and analyzes the image to perform a complete blood count (CBC) – analyzing the number of a patient's red and white blood cells by type and the number of platelets. This is an $8 billion market in the U.S.. where 500 million CBC tests are conducted each year. Gl Show less Read more
Impact Snapshot
Event Time:
SSMXY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SSMXY alerts
Opt-in for
SSMXY alerts

from News Quantified
Opt-in for
SSMXY alerts

from News Quantified